Oxidized low-density lipoprotein and intimal medial thickness in subjects with glucose intolerance-The Chennai Urban Rural Epidemiology Study-25

Metabolism: Clinical and Experimental

Volumn 56, Issue 2, 2007, Pages 245-250

  Gokulakrishnan, Kuppan ^a   Deepa, Raj ^a   Velmurugan, Kaliyaperumal ^a   Ravikumar, Radhakrishnan ^a   Karkuzhali, Kulasekaran ^a   Mohan, Viswanathan ^a  

^a MADRAS DIABETES RESEARCH FOUNDATION   (India)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; OXIDIZED LOW DENSITY LIPOPROTEIN;

ADULT; AGE; ARTICLE; ASIAN; CAROTID ARTERY; CONTROLLED STUDY; CORRELATION ANALYSIS; ECHOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INDIAN; INTIMA; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MULTIPLE LINEAR REGRESSION ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; POPULATION RESEARCH; PRIORITY JOURNAL; RURAL AREA; SEX; THICKNESS; URBAN AREA;

ADULT; ANTHROPOMETRY; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSE INTOLERANCE; HUMANS; INDIA; LIPIDS; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; OXIDATION-REDUCTION; REGRESSION ANALYSIS; RURAL POPULATION; TUNICA INTIMA; URBAN POPULATION;

EID: 33846035727     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2006.10.002     Document Type: Article

References (37)

1. Haffner S.M., Stern M.P., Hazuda H.P., Mitchell B.D., and Patterson J.K. Cardiovascular risk factors in confirmed prediabetic individuals. Does the clock for coronary heart disease start ticking before the onset of clinical diabetes?. JAMA 263 (1990) 2893-2898
2. Mohan V., Deepa R., Rani S.S., and Premalatha G. Prevalence of coronary artery disease and its relationship to lipids in a selected population in South India-The Chennai Urban Population Study (CUPS No. 5). J Am Coll Cardiol 38 (2001) 682-687
3. Kannel W.B. Metabolic risk factors for coronary heart disease in women: perspective from the Framingham Study. Am Heart J 114 (1987) 413-419
4. Mohan V., Gokulakrishnan K., Sandeep S., Srivastava B.K., Ravikumar R., and Deepa R. Carotid intimal medial thickness, glucose intolerance and metabolic syndrome in Asian Indians-The Chennai Urban Rural Epidemiology Study (CURES-22). Diabet Med 23 (2006) 845-850
5. Hunt K.J., Williams K., Rivera D., O'Leary D.H., Haffner S.M., Stern M.P., et al. Elevated carotid artery intima-media thickness levels in individuals who subsequently develop type 2 diabetes. Arterioscler Thromb Vasc Biol 23 (2003) 1845-1850
6. Mohan V., Deepa R., Velmurugan K., and Premalatha G. Association of C-reactive protein with body fat, diabetes and coronary artery disease in Asian Indians-The Chennai Urban Rural Epidemiology Study (CURES-6). Diabet Med 22 (2005) 863-870
7. Hulthe J., and Fagerberg B. Circulating oxidized LDL is associated with subclinical atherosclerosis development and inflammatory cytokines (AIR Study). Arterioscler Thromb Vasc Biol 22 (2002) 1162-1167
8. Gokulakrishnan K., Deepa R., Mohan V., and Gross M.D. Soluble P-selectin and CD40L levels in subjects with pre-diabetes, diabetes mellitus and metabolic syndrome-The Chennai Urban Rural Epidemiology Study (CURES-16). Metabolism 55 (2006) 237-242
9. Ridker P.M., Buring J.E., and Rifai N. Soluble P-selectin and the risk of future cardiovascular events. Circulation 103 (2001) 491-495
10. Ceriello A., and Motz E. Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited. Arterioscler Thromb Vasc Biol 24 (2004) 816-823
11. Goldstein J.L., Ho Y.K., Basu S.K., and Brown M.S. Binding site on macrophages that mediates uptake and degradation of acetylated low-density lipoprotein, producing massive cholesterol deposition. Proc Natl Acad Sci U S A 76 (1979) 333-337
12. Holvoet P., Vanhaecke J., Janssens S., Van de Werf F., and Collen D. Oxidized LDL and malondialdehyde-modified LDL in patients with acute coronary syndromes and stable coronary artery disease. Circulation 98 (1998) 1487-1494
13. Faviou E., Vourli G., Nounopoulos C., Zachari A., and Dionyssiou-Asteriou A. Circulating oxidized low density lipoprotein, autoantibodies against them and homocysteine serum levels in diagnosis and estimation of severity of coronary artery disease. Free Radic Res 39 (2005) 419-429
14. Holvoet P., Mertens A., Verhamme P., Bogaerts K., Beyens G., Verhaeghe R., et al. Circulating oxidized LDL is a useful marker for identifying patients with coronary artery disease. Arterioscler Thromb Vasc Biol 21 (2001) 844-848
15. Steinberg D. Low density lipoprotein oxidation and its pathobiological significance. J Biol Chem 272 (1997) 20963-20966
16. Steinberg D. Oxidative modification of LDL and atherogenesis. Circulation 95 (1997) 1062-1071
17. Berliner J.A., Navab M., Fogelman A.M., Frank J.S., Demer L.L., Edwards P.A., et al. Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics. Circulation 91 (1995) 2488-2496
18. Heinecke J.W. Oxidants and antioxidants in the pathogenesis of atherosclerosis: implications for the oxidized low-density lipoprotein hypothesis. Atherosclerosis 141 (1998) 1-15
19. Metso S., Loimaala A., Mercuri M.F., Nenonen A., Vuori I., Oja P., et al. Circulating oxidized low-density lipoprotein and common carotid artery intima-media thickness in a random sample of middle-aged men. J Biomed Sci 11 (2004) 356-361
20. Mohan V., Shanthirani C.S., and Deepa R. Glucose intolerance (diabetes and IGT) in a selected South Indian population with special reference to family history, obesity and life style factors-The Chennai Urban Population Study (CUPS 14). J Assoc Physicians India 51 (2003) 771-777
21. Wild S., Roglic G., Green A., Sicree R., and King H. Global prevalence of diabetes, estimates for the year 2000 and projections for 2030. Diabetes Care 27 (2004) 1047-1053
22. Reddy K.S., and Yusuf S. Emerging epidemic of cardiovascular disease in developing countries. Circulation 97 (1998) 596-601
23. Deepa M., Pradeepa R., Rema M., Mohan A., Deepa R., Shanthirani S., et al. The Chennai Urban Rural Epidemiology Study (CURES)-study design and methodology (urban component) (CURES-I). J Assoc Physicians India 51 (2003) 863-870
24. Rema M., Mohan V., Deepa R., and Ravikumar R. Association of carotid intima-media thickness and arterial stiffness with diabetic retinopathy: the Chennai Urban Rural Epidemiology Study (CURES-2). Diabetes Care 27 (2004) 1962-1967
25. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of diabetes mellitus. Diabetes Care 20 (1997) 1183-1197
26. Alberti K.G., and Zimmet P.Z. Definition diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus, provisional report of a WHO Consultation. Diabet Med 15 (1998) 539-553
27. Mohan V., Ravikumar R., Shanthi Rani S., and Deepa R. Intimal medial thickness of the carotid artery in south Indian diabetic and nondiabetic subjects: the Chennai Urban Population Study (CUPS). Diabetologia 43 (2000) 494-499
28. Ravikumar R., Deepa R., Shanthirani C.S., and Mohan V. Comparison of carotid intima-media thickness, arterial stiffness and brachial artery flow medicated dilatation in diabetic and non-diabetic subjects. (The Chennai Urban Population Study [CUPS NO:9]. Am J Cardiol 90 (2002) 702-707
29. Lonn E., Yusuf S., Dzavik V., Doris C., Yi Q., Smith S., et al. Effects of ramipril and vitamin E on atherosclerosis: the study to evaluate carotid ultrasound changes in patients treated with ramipril and vitamin E (SECURE). Circulation 103 (2001) 919-925
30. Friedewald W.T., Levy R.I., and Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 18 (1972) 499-502
31. Yla-Herttuala S. Is oxidized low-density lipoprotein present in vivo?. Curr Opin Lipidol 9 (1998) 337-344
32. Chisolm III G.M., Hazen S.L., Fox P.L., and Cathcart M.K. The oxidation of lipoproteins by monocytes-macrophages. Biochemical and biological mechanisms. J Biol Chem 274 (1999) 25959-25962
33. Heery J.M., Kozak M., Stafforini D.M., Jones D.A., Zimmerman G.A., McIntyre T.M., et al. Oxidatively modified LDL contains phospholipids with platelet-activating factor-like activity and stimulates the growth of smooth muscle cells. J Clin Invest 96 (1995) 2322-2330
34. Berg T.J., Snorgaard O., Faber J., Torjesen P.A., Hildebrandt P., Mehlsen J., et al. Serum levels of advanced glycation end products are associated with left ventricular diastolic function in patients with type 1 diabetes. Diabetes Care 22 (1999) 1186-1190
35. Gyongyosi M., Yang P., Hassan A., Weidinger F., Domanovits H., Laggner A., et al. Coronary risk factors influence plaque morphology in patients with unstable angina. Coron Artery Dis 10 (1999) 211-219
36. Kopprasch S., Pietzsch J., Kuhlisch E., Fuecker K., Temelkova-Kurktschiev T., Hanefeld M., et al. In vivo evidence for increased oxidation of circulating LDL in impaired glucose tolerance. Diabetes 51 (2002) 3102-3106
37. Wallenfeldt K., Fagerberg B., Wikstrand J., and Hulthe J. Oxidized low-density lipoprotein in plasma is a prognostic marker of subclinical atherosclerosis development in clinically healthy men. J Intern Med 256 (2004) 413-420